Detalhe da pesquisa
1.
Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
J Infect Dis
; 226(3): 431-440, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584386
2.
Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for hepatitis C virus infection.
J Gastroenterol Hepatol
; 37(2): 371-377, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618379
3.
Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals.
J Gastroenterol Hepatol
; 37(1): 190-199, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374128
4.
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.
Liver Int
; 40(7): 1578-1589, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32304611
5.
Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis.
Hepatol Res
; 50(2): 174-181, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31634412
6.
Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study.
Hepatol Res
; 49(6): 617-626, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30849206
7.
Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study.
Aliment Pharmacol Ther
; 56(4): 713-722, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35735794
8.
Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study.
Hepatol Int
; 16(2): 282-293, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075593
9.
Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma.
Intern Med
; 61(21): 3157-3164, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328582
10.
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study.
Medicine (Baltimore)
; 101(40): e30871, 2022 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36221372
11.
Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C.
Cancers (Basel)
; 12(9)2020 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32933027
12.
Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney disease.
Antiviral Res
; 159: 143-152, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30300717
13.
Radiation-induced hemorrhagic duodenitis associated with sorafenib treatment.
Clin J Gastroenterol
; 8(3): 116-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25832768